Breaking News...anti-cholestoral drug....This will be huge!
AP Avanir Gets First AstraZeneca Payment
Avanir Pharmaceuticals Gets First AstraZeneca Milestone Payment for Cholesterol Drug
SAN DIEGO (AP) -- Drug developer Avanir Pharmaceuticals said it will receive a $5 million payment from British drug maker AstraZeneca PLC now that an early stage clinical trial on a novel cholesterol drug has started. The agreement between the companies, which began in July with a $10 million upfront payment, entitles Avanir to up to $330 million in milestone payments for the development of a reverse cholesterol transport drug that pulls cholesterol from tissues and into the liver where it can be transported to the gall bladder and out of the body.
The $5 million payment was the first milestone received under the agreement.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.